Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The NIHR Oxford Biomedical Research Centre (BRC) has allocated funding to three COVID-19 research projects in an attempt to improve treatment, understand how the virus interacts with chronic diseases, and the longer-term effects of infection on organs.

AVIC scanner at the John Radcliffe Hospital

The funding, originally earmarked for BRC cross-theme cluster projects, has been diverted to research projects in the BRC’s Respiratory, Technology and Digital Health, and Imaging themes.

The Oxford BRC’s Director, Prof Helen McShane, said: “The researchers we support are already at the forefront of national efforts to find a vaccine for COVID-19, and effective treatments for patients – both in hospitals and general practice – who have contracted the virus.

“Such is the breadth of expertise in our BRC – whether in immunology, technology, big data or imaging – that we are especially well placed to address many different aspects of this pandemic, from developing treatments in the short-term, to looking at the longer-term impacts of the virus.

“For this reason, we have released funds to get these projects up and running as quickly as possible so that as many patients can benefit as possible.”

Read the full story on the NIHR Oxford Biomedical Research Centre (BRC) website